|
Eine Ebene nach oben |
Gruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 15
2021
Hein, Alexander; Hartkopf, Andreas D.; Emons, Julius; Lux, Michael P.; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lueftner, Diana; Wurmthaler, Lena A.; Wallwiener, Markus; Mueller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Kurbacher, Christian M.; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas und Kolberg, Hans-Christian
(2021):
Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status.
In: European Journal of Cancer, Bd. 155: S. 1-12
Lux, Michael P.; Schneeweiss, Andreas; Hartkopf, Andreas D.; Mueller, Volkmar; Janni, Wolfgang; Belleville, Erik; Stickeler, Elmar; Thill, Marc; Fasching, Peter A.; Kolberg, Hans-Christian; Untch, Michael; Harbeck, Nadia; Woeckel, Achim; Thomssen, Christoph; Schulmeyer, Carla E.; Welslau, Manfred; Overkamp, Friedrich; Schuetz, Florian; Lueftner, Diana und Ditsch, Nina
(2021):
Update Breast Cancer 2020 Part 5-Moving Therapies From Advanced to Early Breast Cancer Patients.
In: Geburtshilfe und Frauenheilkunde, Bd. 81, Nr. 4: S. 469-480
Moehler, Markus; Folprecht, Gunnar; Heinemann, Volker; Holch, Julian Walter; Maderer, Annett; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Geissler, Michael; Schulz-Abelius, Armin; Linz, Bernhard; Bernhard, Helga; Paul, Andreas; Schmidtmann, Irene; Potthoff, Karin und Schimanski, Carl Christoph
(2021):
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE-3).
In: International Journal of Cancer, Bd. 150, Nr. 8: S. 1341-1349
2020
Stenzinger, Albrecht; Tilburg, Cornelis M. van; Tabatabai, Ghazaleh; Laenger, Florian; Graf, Norbert; Griesinger, Frank; Heukamp, Lukas C.; Hummel, Michael; Klingebiel, Thomas; Hettmer, Simone; Vokuhl, Christian; Merkelbach-Bruse, Sabine; Overkamp, Friedrich; Reichardt, Peter; Scheer, Monika; Weichert, Wilko; Westphalen, C. Benedikt; Bokemeyer, Carsten; Ivanyi, Philipp; Loges, Sonja; Schirmacher, Peter; Woermann, Bernhard; Bielack, Stefan und Seufferlein, Thomas T. W.
(2020):
Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen.
In: Pathologe, Bd. 42, Nr. 1: S. 103-115
Schneeweiss, Andreas; Ettl, Johannes; Lueftner, Diana; Beckmann, Matthias W.; Belleville, Erik; Fasching, Peter A.; Fehm, Tanja N.; Geberth, Matthias; Haberle, Lothar; Hadji, Peyman; Hartkopf, Andreas D.; Hielscher, Carsten; Huober, Jens; Ruckhaberle, Eugen; Janni, Wolfgang; Kolberg, Hans Christian; Kurbacher, Christian M.; Klein, Evelyn; Lux, Michael P.; Müller, Volkmar; Nabieva, Naiba; Overkamp, Friedrich; Tesch, Hans; Laakmann, Elena; Taran, Florin-Andrei; Seitz, Julia; Thomssen, Christoph; Untch, Michael; Wimberger, Pauline; Würstlein, Rachel; Volz, Bernhard; Wallwiener, Diethelm; Wallwiener, Markus und Brucker, Sara Y.
(2020):
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany.
In: Breast, Bd. 54: S. 88-95
Laakmann, Elena; Emons, Julius; Taran, Florin-Andrei; Janni, Wolfgang; Uhrig, Sabrina; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lueftner, Diana; Wallwiener, Markus; Schulmeyer, Carla; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Kurbacher, Christian; Würstlein, Rachel; Thomssen, Christoph; Untch, Michael; Volz, Bernhard; Fasching, Peter A.; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas und Hartkopf, Andreas D.
(2020):
Treatment Landscape and Prognosis After Treatment with Trastuzumab Emtansine.
In: Geburtshilfe und Frauenheilkunde, Bd. 80, Nr. 11: S. 1134-1142
Schimanski, Carl Christoph; Kasper, Stefan; Hegewisch-Becker, Susanna; Schroeder, Jan; Overkamp, Friedrich; Kullmann, Frank; Bechstein, Wolf Otto; Voehringer, Matthias; Oellinger, Robert; Lordick, Florian; Heinemann, Volker; Geissler, Michael; Schulz-Abelius, Armin; Bernhard, Helga; Schoen, Michael R.; Greil, Richard; Galle, Peter; Lang, Hauke; Schmidtmann, Irene und Moehler, Markus
(2020):
Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC).
In: Oncoimmunology, Bd. 9, Nr. 1, 1806680
Michel, Laura L.; Hartkopf, Andreas D.; Fasching, Peter A.; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haberle, Lothar; Ettl, Johannes; Luftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Volz, Bernhard; Huebner, Hanna; Wimberger, Pauline; Hielscher, Carsten; Mundhenke, Christoph; Kurbacher, Christian; Würstlein, Rachel; Untch, Michael; Overkamp, Friedrich; Huober, Jens; Janni, Wolfgang; Taran, Florin-Andrei; Lux, Michael P.; Wallwiener, Diethelm; Brucker, Sara Y.; Schneeweiss, Andreas und Fehm, Tanja N.
(2020):
Progression-Free Survival and Overall Survival in Patients with Advanced HER2-Positive Breast Cancer Treated with Trastuzumab Emtansine (T-DM1) after Previous Treatment with Pertuzumab.
In: Cancers, Bd. 12, Nr. 10, 3021
2019
Lux, Michael P.; Nabieva, Naiba; Hartkopf, Andreas D.; Huober, Jens; Volz, Bernhard; Taran, Florin-Andrei; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lueftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Abenhardt, Wolfgang; Kurbacher, Christian; Wuerstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Schneeweiss, Andreas und Brucker, Sara Y.
(2019):
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry.
In: Cancers, Bd. 11, Nr. 1, 10
Janning, Melanie; Müller, Volkmar; Vettorazzi, Eik; Cubas-Cordova, Miguel; Gensch, Victoria; Ben-Batalla, Isabel; Eulenburg, Christine zu; Schem, Christian; Fasching, Peter A.; Schnappauf, Benjamin; Karn, Thomas; Fehm, Tanja; Just, Marianne; Kühn, Thorsten; Holms, Frank; Overkamp, Friedrich; Krabisch, Petra; Rack, Brigitte; Denkert, Carsten; Untch, Michael; Tesch, Hans; Rezai, Mahdi; Kittel, Kornelia; Pantel, Klaus; Bokemeyer, Carsten; Loibl, Sibylle; Minckwitz, Gunter von und Loges, Sonja
(2019):
Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial.
In: International Journal of Cancer, Bd. 145, Nr. 3: S. 857-868
2018
Hartkopf, Andreas D.; Huober, Jens; Volz, Bernhard; Nabieva, Naiba; Taran, Florin-Andrei; Schwitulla, Judith; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Haeberle, Lothar; Ettl, Johannes; Lux, Michael P.; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Beckmann, Matthias W.; Belleville, Erik; Wimberger, Pauline; Hielscher, Carsten; Geberth, Matthias; Fersis, Nikos; Abenhardt, Wolfgang; Kurbacher, Christian; Würstlein, Rachel; Thomssen, Christoph; Untch, Michael; Fasching, Peter A.; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Brucker, Sara Y. und Schneeweiss, Andreas
(2018):
Treatment landscape of advanced breast cancer patients with hormone receptor positive HER2 negative tumors - Data from the German PRAEGNANT breast cancer registry.
In: Breast, Bd. 37: S. 42-51
2016
Thomssen, Christoph; Augustin, Doris; Ettl, Johannes; Haidinger, Renate; Lück, Hans-Joachim; Lueftner, Diana; Marmé, Frederik; Marschner, Norbert; Müller, Lothar; Overkamp, Friedrich; Ruckhäberle, Eugen; Thill, Marc; Untch, Michael; Wuerstlein, Rachel und Harbeck, Nadia
(2016):
ABC3 Consensus: Assessment by a German Group of Experts.
In: Breast Care, Bd. 11, Nr. 1: S. 61-70
[PDF, 93kB]
Hein, Alexander; Gass, Paul; Walter, Christina Barbara; Taran, Florin-Andrei; Hartkopf, Andreas; Overkamp, Friedrich; Kolberg, Hans-Christian; Hadji, Peyman; Tesch, Hans; Ettl, Johannes; Wuerstlein, Rachel; Lounsbury, Debra; Lux, Michael P.; Lüftner, Diana; Wallwiener, Markus; Müller, Volkmar; Belleville, Erik; Janni, Wolfgang; Fehm, Tanja N.; Wallwiener, Diethelm; Ganslandt, Thomas; Ruebner, Matthias; Beckmann, Matthias W.; Schneeweiss, Andreas; Fasching, Peter A. und Brucker, Sara Y.
(2016):
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients.
In: Breast Cancer Research and Treatment, Bd. 158, Nr. 1: S. 59-65
2013
Bergmann, Lothar; Goebell, Peter J.; Kube, Ulrich; Kindler, Manfred; Herrmann, Edwin; Janssen, Jan; Schmitz, Joerg; Weikert, Steffen; Steiner, Gabriel; Jakob, Andreas; Staehler, Michael D.; Steiner, Thomas; Overkamp, Friedrich; Albrecht, Michael; Guderian, Gernot und Doehn, Christian
(2013):
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study.
In: Onkologie, Nr. 3: S. 95-100
[PDF, 441kB]
2012
Schimanski, Carl Christoph; Möhler, Markus; Schön, Michael; Cutsem, Eric van; Greil, Richard; Bechstein, Wolf Otto; Hegewisch-Becker, Susanna; Wichert, Götz von; Vöhringer, Matthias; Heike, Michael; Heinemann, Volker; Peeters, Marc; Kanzler, Stephan; Kasper, Stefan; Overkamp, Friedrich; Schröder, Jan; Seehofer, Daniel; Kullmann, Frank; Linz, Bernhard; Schmidtmann, Irene; Smith-Machnow, Victoria; Gockel, Ines; Lang, Hauke und Galle, Peter R.
(2012):
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases-a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
In: BMC Cancer
12:144
[PDF, 1MB]